Cardiology

Despite the results of a large-scale trial, some experts questioned the use of beta-blockers for patients that suffered from heart failure and simultaneous AFib when in the presence of beta-adverse medications, like amiodarone.

The valve is the first stented surgical aortic valve that is MRI-safe without restrictions and uses single, one-cut release to increase the ease of implantation.

A secondary study revealed that the presence of diabetes mellitus in patients with chronic heart failure leads to a higher risk of early death.

True or false: Between 1999-2004 and 2005-2010, cancer replaced CV/CHD as leading cause of death in T2D.

The 2017 lipid management guidelines have met both accolades and controversy. Take our quick quiz on the updates.

Caution: Approach every patient with SLE as a “bundle of cardiovascular risks” greater than the sum of its parts

The FDA expanded approval of a self-expanding TAVR platform to include patients who are at an intermediate risk for open-heart surgery.

Though safer for relapsing-remmitting multiple sclerosis than new disease-modifying therapies, the treatment nearly doubles the chance of a patient suffering from a stroke.

L-glutamine is the first SCD treatment approved for pediatric patients, and the first adult treatment approved in nearly 20 years.

The drug reduced risk of overall symptomatic hypoglycemia compared to insulin glargine U100.

Karol Watson, MD, shares her professional and personal perspective on what a prophylaxis means for especially older VTE patients.

What the Type 2 diabetes treatment could do if approved for cardiovascular events, according to Karol Watson, MD.

A meta-analysis provides no support for theory that incretin-based treatment causes increased mortality in patients with T2D.

High-amylose maize starch with chemical add-ons prevented diabtes in susceptible mice in an Australian study.

Despite its recent success, Morgan Stanley experts give the drug 5% odds of reaching markets.

Pioglitazone actions on reducing insulin resistance could mediate changes in renal function.

The AACE/ACE 2017 recommendations on lipid management prescribe LDL-C targets, and go far lower than any group has ventured to date.

The treatment was tested in a trial of 7,513 patients hospitalized and susceptible to the condition.

The subcutaneous treatment can be used for HAE attacks at home.

The drug reduced cardiovascular risk in people with prior heart attack and inflammatory atherosclerosis.

The CANVAS results yield promise against cardiovascular events, but a risk of amputations.

Maternal use of lithium in the first trimester raises risk of cardiac defects to the fetus.

Benefit was seen in 5 countries regardless of SGLT2 inhibitor used.

Her history includes diabetes, ESRD, coronary disease, and complete heart block after pacemaker implantation. What's your ECG read?

Results have major worldwide implications for type 2 diabetes treatment.

New-generation insulin found to have comparable cardiovascular safety to insulin glargine and significantly reduce episodes of severe hypoglycemia.

85% of patients experienced improvement in heart failure symptoms

The FDA determined Sentinel is effective in capturing debris caused by TAVR.

High HbA1c levels after the percutaneous cardiovascular intervention may help identify patients at long-term risk for adverse CV events.